SNOMED CT, US Edition

Last uploaded: March 22, 2026
Id http://purl.bioontology.org/ontology/SNOMEDCT/405917009
http://purl.bioontology.org/ontology/SNOMEDCT/405917009
Preferred Name

Intergroup rhabdomyosarcoma study post-surgical clinical group finding
Synonyms
Intergroup rhabdomyosarcoma study post-surgical clinical group finding (finding)
Type http://www.w3.org/2002/07/owl#Class

All Properties

prefLabel
Intergroup rhabdomyosarcoma study post-surgical clinical group finding
altLabel
Intergroup rhabdomyosarcoma study post-surgical clinical group finding (finding)
Type ID
900000000000003001
900000000000013009
Semantic type UMLS property
interprets
Effective time
20040131
cui
C1320618
CTV3ID
XUaRO
DEFINITION STATUS ID
900000000000074008
CASE SIGNIFICANCE ID
900000000000448009
tui
T033
Active
1
Has associated morphology
notation
405917009
type
subClassOf
Subset member
6011000124106~MAPADVICE~IF INTERGROUP RHABDOMYOSARCOMA STUDY POST-SURGICAL CLINICAL GROUP IV: ANY SIZE PRIMARY TUMOR, WITH OR WITHOUT REGIONAL LYMPH NODE INVOLVEMENT, WITH DISTANT METASTASES, WITHOUT RESPECT TO SURGICAL APPROACH TO PRIMARY TUMOR CHOOSE C79.9 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPRULE~IFA 405961001 | Intergroup rhabdomyosarcoma study post-surgical clinical group IIC: Locally extensive tumor (spread to regional lymph nodes), gross total resection, but microscopic residual disease (finding) |
447562003~MAPRULE~TRUE
6011000124106~MAPADVICE~IF INTERGROUP RHABDOMYOSARCOMA STUDY POST-SURGICAL CLINICAL GROUP IA: LOCALIZED TUMOR, CONFINED TO SITE OF ORIGIN, COMPLETELY RESECTED CHOOSE Z85.831 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPRULE~IFA 405964009 | Intergroup rhabdomyosarcoma study post-surgical clinical group IV: Any size primary tumor, with or without regional lymph node involvement, with distant metastases, without respect to surgical approach to primary tumor |
6011000124106~MAPADVICE~IF INTERGROUP RHABDOMYOSARCOMA STUDY POST-SURGICAL CLINICAL GROUP IIC: LOCALLY EXTENSIVE TUMOR (SPREAD TO REGIONAL LYMPH NODES), GROSS TOTAL RESECTION, BUT MICROSCOPIC RESIDUAL DISEASE CHOOSE Z85.831 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPPRIORITY~7
6011000124106~MAPPRIORITY~4
6011000124106~MAPRULE~IFA 405960000 | Intergroup rhabdomyosarcoma study post-surgical clinical group IIB: Locally extensive tumor (spread to regional lymph nodes), completely resected |
6011000124106~MAPTARGET~Z85.831
6011000124106~MAPADVICE~IF INTERGROUP RHABDOMYOSARCOMA STUDY POST-SURGICAL CLINICAL GROUP IIB: LOCALLY EXTENSIVE TUMOR (SPREAD TO REGIONAL LYMPH NODES), COMPLETELY RESECTED CHOOSE Z85.831 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPADVICE~MAP SOURCE CONCEPT CANNOT BE CLASSIFIED WITH AVAILABLE DATA
6011000124106~MAPRULE~IFA 405961001 | Intergroup rhabdomyosarcoma study post-surgical clinical group IIC: Locally extensive tumor (spread to regional lymph nodes), gross total resection, but microscopic residual disease |
6011000124106~MAPRULE~IFA 405962008 | Intergroup rhabdomyosarcoma study post-surgical clinical group IIIA: Localized or locally extensive tumor, gross residual disease after biopsy only |
6011000124106~MAPTARGET~
6011000124106~MAPCATEGORYID~447638001
6011000124106~MAPRULE~IFA 405964009 | Intergroup rhabdomyosarcoma study post-surgical clinical group IV: Any size primary tumor, with or without regional lymph node involvement, with distant metastases, without respect to surgical approach to primary tumor (finding) |
6011000124106~MAPADVICE~IF INTERGROUP RHABDOMYOSARCOMA STUDY POST-SURGICAL CLINICAL GROUP IIIA: LOCALIZED OR LOCALLY EXTENSIVE TUMOR, GROSS RESIDUAL DISEASE AFTER BIOPSY ONLY CHOOSE Z98.890 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPGROUP~1
6011000124106~MAPGROUP~2
6011000124106~MAPADVICE~IF INTERGROUP RHABDOMYOSARCOMA STUDY POST-SURGICAL CLINICAL GROUP IIA: LOCALIZED TUMOR, GROSS TOTAL RESECTION, BUT WITH MICROSCOPIC RESIDUAL DISEASE CHOOSE Z85.831 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPADVICE~IF INTERGROUP RHABDOMYOSARCOMA STUDY POST-SURGICAL CLINICAL GROUP IIB: LOCALLY EXTENSIVE TUMOR CHOOSE Z85.831 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
900000000000497000~MAPTARGET~XUaRO
447562003~MAPADVICE~MAP SOURCE CONCEPT CANNOT BE CLASSIFIED WITH AVAILABLE DATA
6011000124106~MAPADVICE~IF INTERGROUP RHABDOMYOSARCOMA STUDY POST-SURGICAL CLINICAL GROUP IIIB: LOCALIZED OR LOCALLY EXTENSIVE TUMOR, GROSS RESIDUAL DISEASE AFTER MAJOR RESECTION (GREATER THAN 50% DEBULKING) CHOOSE C49.9 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPPRIORITY~8
6011000124106~MAPRULE~IFA 405957007 | Intergroup rhabdomyosarcoma study post-surgical clinical group IA: localized tumor, confined to site of origin, completely resected |
6011000124106~MAPADVICE~IF INTERGROUP RHABDOMYOSARCOMA STUDY POST-SURGICAL CLINICAL GROUP IIC: LOCALLY EXTENSIVE TUMOR (SPREAD TO REGIONAL LYMPH NODES), GROSS TOTAL RESECTION, BUT MICROSCOPIC RESIDUAL DISEASE CHOOSE Z98.890 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPADVICE~IF INTERGROUP RHABDOMYOSARCOMA STUDY POST-SURGICAL CLINICAL GROUP IIB: LOCALLY EXTENSIVE TUMOR (SPREAD TO REGIONAL LYMPH NODES), COMPLETELY RESECTED CHOOSE Z98.890 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
447562003~MAPGROUP~1
447562003~CORRELATIONID~447561005
6011000124106~MAPTARGET~C79.9
6011000124106~MAPADVICE~IF INTERGROUP RHABDOMYOSARCOMA STUDY POST-SURGICAL CLINICAL GROUP IIIB: LOCALIZED OR LOCALLY EXTENSIVE TUMOR, GROSS RESIDUAL DISEASE AFTER MAJOR RESECTION CHOOSE C49.9 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
900000000000509007~ACCEPTABILITYID~900000000000548007
6011000124106~MAPRULE~IFA 405959005 | Intergroup rhabdomyosarcoma study post-surgical clinical group IIA: localized tumor, gross total resection, but with microscopic residual disease |
6011000124106~MAPRULE~IFA 405958002 | Intergroup rhabdomyosarcoma study post-surgical clinical group IB: localized tumor, infiltrating beyond site of origin, completely resected (finding) |
6011000124106~MAPRULE~IFA 405959005 | Intergroup rhabdomyosarcoma study post-surgical clinical group IIA: localized tumor, gross total resection, but with microscopic residual disease (finding) |
900000000000508004~ACCEPTABILITYID~900000000000548007
6011000124106~MAPADVICE~IF INTERGROUP RHABDOMYOSARCOMA STUDY POST-SURGICAL CLINICAL GROUP IIC: LOCALLY EXTENSIVE TUMOR CHOOSE Z98.890 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPRULE~IFA 405958002 | Intergroup rhabdomyosarcoma study post-surgical clinical group IB: localized tumor, infiltrating beyond site of origin, completely resected |
447562003~MAPTARGET~
6011000124106~MAPADVICE~IF INTERGROUP RHABDOMYOSARCOMA STUDY POST-SURGICAL CLINICAL GROUP IIC: LOCALLY EXTENSIVE TUMOR CHOOSE Z85.831 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPADVICE~IF INTERGROUP RHABDOMYOSARCOMA STUDY POST-SURGICAL CLINICAL GROUP IA: LOCALIZED TUMOR, CONFINED TO SITE OF ORIGIN, COMPLETELY RESECTED CHOOSE Z98.890 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPRULE~IFA 405963003 | Intergroup rhabdomyosarcoma study post-surgical clinical group IIIB: Localized or locally extensive tumor, gross residual disease after major resection (greater than 50 percent debulking) |
447562003~MAPPRIORITY~1
6011000124106~MAPADVICE~IF INTERGROUP RHABDOMYOSARCOMA STUDY POST-SURGICAL CLINICAL GROUP IIC: LOCALLY EXTENSIVE TUMOR (SPREAD TO REGIONAL LYMPH NODES), GROSS TOTAL RESECTION, BUT MICROSCOPIC RESIDUAL DISEASE CHOOSE C77.9 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPTARGET~C77.9
6011000124106~MAPRULE~OTHERWISE TRUE
6011000124106~MAPPRIORITY~5
6011000124106~MAPTARGET~C49.9
6011000124106~MAPPRIORITY~9
6011000124106~MAPCATEGORYID~447639009
6011000124106~MAPRULE~IFA 405962008 | Intergroup rhabdomyosarcoma study post-surgical clinical group IIIA: Localized or locally extensive tumor, gross residual disease after biopsy only (finding) |
6011000124106~MAPTARGET~Z98.890
6011000124106~MAPADVICE~IF INTERGROUP RHABDOMYOSARCOMA STUDY POST-SURGICAL CLINICAL GROUP IIIB: LOCALIZED OR LOCALLY EXTENSIVE TUMOR, GROSS RESIDUAL DISEASE AFTER MAJOR RESECTION CHOOSE Z98.890 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPADVICE~IF INTERGROUP RHABDOMYOSARCOMA STUDY POST-SURGICAL CLINICAL GROUP IV: ANY SIZE PRIMARY TUMOR, WITH OR WITHOUT REGIONAL LYMPH NODE INVOLVEMENT, WITH DISTANT METASTASES, WITHOUT RESPECT TO SURGICAL APPROACH TO PRIMARY TUMOR CHOOSE Z98.890 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPADVICE~IF INTERGROUP RHABDOMYOSARCOMA STUDY POST-SURGICAL CLINICAL GROUP IV: ANY SIZE PRIMARY TUMOR, WITH OR WITHOUT REGIONAL LYMPH NODE INVOLVEMENT, WITH DISTANT METASTASES, WITHOUT RESPECT TO SURGICAL APPROACH TO PRIMARY TUMOR CHOOSE C49.9 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPADVICE~IF INTERGROUP RHABDOMYOSARCOMA STUDY POST-SURGICAL CLINICAL GROUP IB: LOCALIZED TUMOR, INFILTRATING BEYOND SITE OF ORIGIN, COMPLETELY RESECTED CHOOSE Z98.890 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPPRIORITY~1
6011000124106~MAPRULE~IFA 405957007 | Intergroup rhabdomyosarcoma study post-surgical clinical group IA: localized tumor, confined to site of origin, completely resected (finding) |
6011000124106~MAPPRIORITY~6
6011000124106~CORRELATIONID~447561005
6011000124106~MAPADVICE~IF INTERGROUP RHABDOMYOSARCOMA STUDY POST-SURGICAL CLINICAL GROUP IIB: LOCALLY EXTENSIVE TUMOR CHOOSE Z98.890 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPADVICE~IF INTERGROUP RHABDOMYOSARCOMA STUDY POST-SURGICAL CLINICAL GROUP IIC: LOCALLY EXTENSIVE TUMOR CHOOSE C77.9 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPRULE~TRUE
6011000124106~MAPGROUP~3
6011000124106~MAPADVICE~IF INTERGROUP RHABDOMYOSARCOMA STUDY POST-SURGICAL CLINICAL GROUP IB: LOCALIZED TUMOR, INFILTRATING BEYOND SITE OF ORIGIN, COMPLETELY RESECTED CHOOSE Z85.831 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPPRIORITY~3
6011000124106~MAPRULE~IFA 405960000 | Intergroup rhabdomyosarcoma study post-surgical clinical group IIB: Locally extensive tumor (spread to regional lymph nodes), completely resected (finding) |
6011000124106~MAPADVICE~IF INTERGROUP RHABDOMYOSARCOMA STUDY POST-SURGICAL CLINICAL GROUP IIIB: LOCALIZED OR LOCALLY EXTENSIVE TUMOR, GROSS RESIDUAL DISEASE AFTER MAJOR RESECTION (GREATER THAN 50% DEBULKING) CHOOSE Z98.890 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPADVICE~IF INTERGROUP RHABDOMYOSARCOMA STUDY POST-SURGICAL CLINICAL GROUP IIA: LOCALIZED TUMOR, GROSS TOTAL RESECTION, BUT WITH MICROSCOPIC RESIDUAL DISEASE CHOOSE Z98.890 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPPRIORITY~2
447562003~MAPCATEGORYID~447638001
6011000124106~MAPADVICE~IF INTERGROUP RHABDOMYOSARCOMA STUDY POST-SURGICAL CLINICAL GROUP IIIA: LOCALIZED OR LOCALLY EXTENSIVE TUMOR, GROSS RESIDUAL DISEASE AFTER BIOPSY ONLY CHOOSE C49.9 | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPRULE~IFA 405963003 | Intergroup rhabdomyosarcoma study post-surgical clinical group IIIB: Localized or locally extensive tumor, gross residual disease after major resection (greater than 50% debulking) (finding) |
See more
See less
Add comment
Add proposal
Delete Subject Author Type Created
No notes to display